华根霉cDNA文库的构建及纤溶酶基因的筛选和功能鉴定
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
血栓栓塞性疾病严重威胁人类生命和健康,溶栓治疗是血栓性疾病安全有效的治疗手段。目前临床使用的溶栓药物疗效肯定,但还存在许多缺陷,而且价格昂贵。因此研制高效、快速、副作用小,价廉的新型溶栓药物成为当前的迫切需求。
     本试验构建了华根霉全长cDNA文库,并从中筛选出一种根霉纤溶酶基因;通过其在毕赤酵母中的表达,对该酶的酶学性质进行了初步的研究。
     通过SMART (Switching Mechanism At 5'end of the RNA Transcript)技术构建了华根霉全长cDNA文库。大肠杆菌转化子平板检测和PCR鉴定表明,所构建的文库库容为1.6×109cfu/mL,重组率为91.6%,达到了用于目的基因的分离筛选及克隆表达的建库要求。
     设计了四条简并引物并使用一种PCR方法从cDNA文库中分离出编码根霉纤溶酶的基因。该基因编码279个氨基酸,预测蛋白的分子量为30406 Da。根据基因序列比对得出此基因编码纤溶酶和其他纤溶酶类蛋白没有明显同源性。我们将此基因和pPIC9质粒相连接,构建了毕赤酵母表达载体,并通过在毕赤酵母中的表达对该纤溶酶功能进行了分析。实验结果表明重组工程菌分泌蛋白具有溶解血纤维蛋白的活性。
     本文还对重组纤溶酶的酶学性质进行了研究。SDS-PAGE电泳测定纤溶酶分子量为30 KDa。预测该纤溶酶的等电点为10.23±0.2。重组纤溶酶比活力23.14U/mL,纤溶酶最适作用温度37℃,在4℃~42℃范围内酶活性受环境温度影响较小。讨论了酸碱对该酶活性的影响,得出该酶的最适反应pH 8.4,在pH 6.8~8.8该酶最稳定。该酶对酪蛋白具有水解作用,在和生色底物反应的实验中发现其能水解的底物为D-Ile-Phe-Lys-pNA和N-Sueeinyl-Ala-Ala-Pro-Phe-pNA。在金属离子对酶活的影响试验中得出Zn2+、Fe2+、Cu2+、Mn2+、Co2+离子对酶有不同程度的抑制作用,而且大多数表现为离子浓度越大抑制作用越强。Na+、K+、Ca2+、Mg2+等金属离子对该酶的激活作用并不显著。本实验研究与已报道的华根霉纤溶酶的性质有较大的区别,如等电点,最适温度,pH,底物专一性等方面。说明华根霉能够分泌多种不同性质的纤溶酶,本研究只克隆得到其中一种纤溶酶基因。
Thrombosis intimidates mankind's life and health seriously, fibrinolytic therapy was an effective and safety method to cure it. Currently, fibrinolytic enzymes available for clinical use are mostly plasminogen activators. Despite of their widespread applications, all these agents have undesired side effects and are very expensive. Therefore, searching for novel fibrinolytic enzymes from various sources.is emergency
     In this research, a full-length cDNA library of Rhizopus chinensis has been constructed and a gene encoding fibrinolytic enzyme has been identified from Rhizopus chinensis cDNA library. Also, the characteristics of fibrinolytic enzyme expressed by recombinant Pichia pastor is were studied in this paper.
     The full-length cDNA library of Rhizopus chinensis has been constructed by using SMART (Switching Mechanism At 5'end of RNA Transcript) technology. According to the results of phage plaques bright selection of host bacterial strain and PCR detection, the percentage of recombinant phages was 91.6% and the titer was 1.6×109 cfu/mL, which showed that the library was of high quality for cloning target genes and expressing target proteins.
     Four degenerate primes were designated and a gene encoding hydrolysis fibrin activity protein from Rhizopus chinensis cDNA library was isolated by PCR. The coding region of 279 amino acids suggested a protein of 30 KDa. Sequences blasting, indicated that this protein did not shared homology to other proteins with hydrolysis fibrin activity secreted by animal and other microorganism. Expression vector pPIC9-rcfe was constructed and transformed into Pichia pastor is GS115. The function of rcfe was analyzed by the expression in Pichia pastoris. The result showed obviously that the protein secreted by transformed yeast cells had hydrolysis fibrin activity.
     Further, the characteristics of the fibrinolytic enzyme from recombinant Pichia pastori were studied. The molecular mass was 30.4 KDa determined by SDS-PAGE. The isoelectric point was expected to be 10.23±0.2 as DNAMAN suggested. The enzyme had a specific activity of 23.14U/mL in the optimal temperature of 37℃, and its activity was stable in the temperature ranging from 4℃-42℃; and in the pH of 6.8-8.8; The optimal active temperature and pH was 37℃and 8.4 respectively. The enzyme showed hydrolysis activity against casein. Among the teste synthetic substrates, the enzyme can hydrolyze D-Ile-Phe-Lys-pNA and N-Sueeinyl-Ala-Ala-Pro-Phe-pNA. Zn2+, Fe2+, Fe3+, Cu2+, Mn2+ and Co2+ showed inhibition on the activity of the enzyme, and the inhibition activity was ever increasing as the concentration of these metal ion growing; on the other hand, K+, Na+, Ca2+, Mg2+had no obvious activation effect on the activity of the enzyme. Distinguish properties of fibrinolytic enzyme from Rhizopus chinensis were observed in our study compared with those in previously reported references. Rhizopus chinensis could secrete variety types of fibrinolytic enzyme; only one fibrinolytic enzyme gene has been cloned in this research.
引文
[1]马大龙.生物技术药物[M].北京:科学出版社,2001.
    [2]陆东风.急性心肌梗死溶栓治疗过时了吗.吗心血管疾病防治知识,2008,06:18-19.
    [3]陈修学.心血管药理学[M].人民卫生出版社,2003,737-779.
    [4]Nobuyoshi Nakajima, Manabu Sugimoto, Kohji Ishihara. Earthworm-serine protease: characterization, molecular cloning, and application of the catalytic functions [J]. Journal of Molecular Catalysis B:Enzymatic,2003,23:191-212.
    [5]孙天宵,徐长法.溶栓剂的蛋白质工程[J].生物工程进展,1996,16(2):43-49.
    [6]黄柄辉,陈春麟.临床溶栓药UK与SK生化药理和临床应用比较[J].生化药物杂志,1990,52(2):19-20.
    [7]王鸿利,王学锋,血栓病临床新技术[M].北京:人民军医出版社,2003.
    [8]Datar RV, Cartwright T, Rosen CG.. Process economic of animal cell and bacterial fermentation:A case study analysis of tissue plasminoen activator[J]. Biol Technol, 1993,11:349-355.
    [9]Kohler M, Sen S, Hermes R, et al. Pharmacokinetics of single-chain unrokinase-type plasminogen activator(scu-PA) and two-chain urokinase-type plasminogen activator(tcu-PA) in patients with acute myocardial infarction[J]. Thromb Res,1991, 62(1-2):75-81.
    [10]Sherman DG, Atkinson Rp, Chippendale T, et al. Intrevenous Ancrod for Treatment of Acute Ischemic stroke[J]. JAMA,2000,283(18):2395-2404.
    [11]Verstraete M, Lijner HR, Collen D. Thrombolytic agent in development[J]. Drug, 1995,50(1):29-42.
    [12]刘发益,文志宾,何晓凡,等.XIIa因子受抑稀释凝血活酶试验的影响因素及临床意义[J].中华检验医学杂志,2002,25(3):162-165.
    [13]郭丹.中国黑眼镜蛇毒蛋白酶natrahagin抑制血小板凝集和动脉血栓形成的作用[J].中国药理学与毒理学杂志,2001,15(1):27-30.
    [14]Reyer L. Failuer of asprin at different dose to modify experimental thrombosis in rat[J]. Thromb Res,1980,18:669.
    [15]周元聪,朱洪,陈远聪,等.赤子爱胜蚓(Bisneai foelide)纤溶酶的分离纯化[J].生物化学及生物物理学报,1988,22(1):35-42.
    [16]路英华,金汝成,吴应文,等.锯齿远蚓(Amnythas dancataa)纤溶酶的分离纯化及其若干性质[J].生物化学杂志,1988,4(2):166-172.
    [17]陈奇,陈兰英,毕明.新一代全天然抗血栓药-博洛克[J].中草药,1997,28(5):315-317.
    [18]杨星勇,卢晓风,斐炎.五步蛇溶纤活性蛋白的纯化和性质[J].昆虫学报,1998,41(3):231-236.
    [19]杨星勇,程惊秋,裴炎,等.华广虻(Tabnaus amaenus walker)溶纤活性蛋白的纯化及生物活性分析[J].中国生物化学与分子生物学报,1999,15(4):580-584.
    [20]杨星勇,卢晓风,程惊秋,等.杭州虻纤溶酶的纯化及其生物活性分析[J].动物学报,2000,46(2):160-166.
    [21]裴光源,王中枢.蒲黄“纤溶酶”的分离纯化及部分性质的研究[J].生物化学与生物物理学报,1991,23(1):14-19.
    [22]《科技兴海丛书》编辑委员会编.海洋生物基因与生物工程技术[M].北京:海洋出版社,2001.
    [23]张士璀,范晓,马军英主编.海洋生物技术原理和应用[M].北京:海洋出版社,1998.
    [24]魏春,刘晨光,刘万顺,等.一种来自海洋细菌的血纤维蛋白溶酶的分离纯化及性质研究[J].海洋科学,2001,25(3):1-3.
    [25]Kiminori Matsubrar, Hori K, Yasushi Matsuura, et al. A fibrimolytic enzyme from a marine green alga, Codium latum[J]. Phytoehemistry,1999,52:993-999.
    [26]Kiminori Matsubrar, Hori K, Matsuura Y. Purification and characterization of a fibrinolytic enzyme and identification of fibrinogen clotting enzyme in a marine alga Codium ivaricatum[J]. Comp Biochem Physiol, 2000,125:137-143.
    [27]Bono F, Savi P, TuongA, et al. Puricfation and characterization of a novel Protease from culture filtrates of a Sterptomyces sp[J]. FRMS Micorbiol Lett,1996,141: 213-222.
    [28]Chitte R R, Dey S. Potent fibrinolytic enzyme from a thermophilic Streptomyces megasporus strain SD5[J]. Lett APPL Microbiol,2000,31:405-410.
    [29]王骏,王敏,王以光.链霉菌产生的新型纤溶酶的纯化和性质研究[J].生物工程学报,1999,15(2):147-153.
    [30]武临专,王以光.链霉菌C-3662产生的纤溶活性蛋白酶的纯化和理化性质[J].中国生物化学与分子生物学报,2001,17(1):85-90.
    [31]Toshiaki N, Yoshiyuki O, H Youichi, et al. Isolation and characterization of fibrinogenase from Candida ablicans NH-1[J]. Int J Biochem,1993,25(12):1815-1822.
    [32]SuTao, Liu Beihui, Li Peng, et al. New solid-state fermentation process for repeated batch produetion of fibrinolytic enzyme by Fusarium Oxysporum[J]. Proc Biochem, 1981,33(4):419-422.
    [33]Sumi H, Hamada H, Tsushima H, et al. A novel fibrinolytic enzyme (Nattokinase) in the vegetable cheese Natto, a typical and Popular soybean food in the Jpaanese diet[J]. Experientia,1987,43:1110-1111.
    [34]Fujita M, Nomura K, Hong K, et al. Purification and characterization of a strong fibrinolytiec enzyme (Nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Jpaan[J]. Biochem Biophy Res Commun,1993,197(3):1340-1346.
    [35]Sumi H, Hamada H, Nakanishi K, et al. Enhancement of the fibrinolytic activity in plasma by oarl administration of NK[J]. Acta Hacmatol,1990,84:139-143.
    [36]Chan CT, Fan M H, Kuo FC, et al. Potent fibrinolytic enzyme from amutant of Bacillus subtilis IMR-NK1[J]. Agric, Food Chem.2000,48:3210-16.
    [37]Kim W, Choi K, Kim Y, et al. Purification and characterization of a fibrinolytic enzyme produced from Bacillus sp. Strain CK 11-4 Screened from Chungkook-jang[J]. Appl Environ Microbiol,1996,62(7):2482-2488.
    [38]Kim s, Choi N. Purification and characterization of subtilisin DJ-4 secreted by Bacillus sp. Strain DJ-4 screened from Doen-Jang[J]. Biosci Biotehcnol biochem, 2000,64(8):1722-1725.
    [39]阎家麒,童岩,臧莹安.豆豉纤溶酶的纯化及其性质研究[J].药物生物技术,2000,7(3): 149-152.
    [40]韩润林,张小勇,张建安.枯草杆菌溶栓酶的分离与纯化研究[J].中国生化药物杂志,2000,21(5):219-222.
    [41]杨志兴,张淑梅,张云湖,等.一株具有纤溶活性的枯草杆菌蛋白激酶的初步研究[J].药物生物技术,1996,3(3):233-136.
    [42]Nobuyuki Murayama, Makoto Tanaka, Satoshi Kunitada, et al. Tolerability, pharmacokinetics, and pharmacodynamics of DK-9065a, a new synthetic potent anticoagulnat and specific factor Xa inhibitor, in healthy male volunteers[J]. Clin Phamracol Ther,1999,66:258.
    [43]Yamazaki M, Asakura H, Aoshima K, et al. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induecd experimental disseminated intravascular coagulation in rats[J]. Semin Tromb Hemost,1996,22:255.
    [44]Montoney M, Gardell SJ, Marder VJ, et al. Comparison of the bleeding Potential of vampire bat sailvary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model [J]. Circulation,1995,91:1540.
    [45]Farced J. Current trends in antithrombotic drug and device development [J]. Semin Thromb Hemost,1996,22(suppl 1):3.
    [46]高占争,赵允麟.酱油曲中产纤溶酶微生物的分离筛选和初步鉴定[J].食品与药品A,2006(1):61-63.
    [47]刘晓兰,杜连祥,路福平,等.根霉12号固体发酵产生纤溶酶工艺条件的研究 [J].菌物系统,2003,22(3):481-488.
    [48]刘晓兰,杜连祥,路福平,等.Rhizopus chinensis12#发酵产生纤溶酶的分离提纯[J].无锡轻工大学学报,2003,22(3):26-31.
    [49]刘东,路福平.根霉纤溶酶急性毒性试验研究[J].职业与健康,2004,3(42).
    [50]Galaud JP, Carriere M, Nicolas Pauly, et al. Construction of two ordered cDNA libraries enriched in genes encoding plasmalemma and tonoplast proteins from a high-efficiency expression library[J]. Plant J,1999,17(1):111-118.
    [51]Diatchenko L, Lau YC, Campbeu AP, et al. Isolation and Characterization of Defense Response Genes Involved in Neck Blast Resistance of Rice[J]. Proc Natl Acad Sci USA,1996,93(12):6025-6030.
    [52]王关林,方宏筠.植物基因工程(第二版)[M].北京:科学技术出版社,2002,43-170.
    [53]Sambrook J. Molecular cloning:A laboratory manual,2nd eds[M]. Cold Spring Harbor Lab Press,1989,396-449.
    [54]Peterson LA, Brown MR, Brown AJ, et al. An Improved Method for Construction of Directionally Cloned cDNA Libraries from Microdissected Cells[J]. Cancer Res, 1998,58(23):5326-5328.
    [55]Hawkins V, Nelson PS, Schummer M, et al. Negative selection:a method for obtaining low-abundance cDNAs using high-density cDNA clone arrays[J]. Nucleic Acids Res,1999,27(1):204-208.
    [56]Hofstetter H, Schambock A, Van Den Berg J, et al. Specific excision of the inserted DNA segment from hybrid plasmids constructed by the poly(dA), Poly (dT) method[J]. Biochim Biophys Acta.,1976,13,454(3):587-91.
    [57]Young RA, Davis RW. Efficient Isolation of Genes by Using Antibody Probes[J]. Proc Natl Acad Sci,1983,80:1194-1198.
    [58]Aguan K, Kusano T, Suzuki N, et al. An improved method for the construction of high efficiency cDNA library in plasmid or lambda vector[J]. Nucleic Acids Res,1990,8: 1071.
    [59]Clarke L, Carbon J. A colony bank containing synthetic Col El hybrid plasmids representative of the entire E. coli genome[J]. Cell,1976,9(1):91-9.
    [60]Roeder T, Schramm G, Bruchhaus I, et al. A simple and reliable 5'-RACE approach[J]. Nucleic Acids Res,1998,26:3451-3452.
    [61]Kato S, Sekine S, Oh S W, et al. Construction of a human full-length cDNA bank[J]. Gene,1994,15; 150(2):243-50.
    [62]Suzuki Y, Maruyama K, Suyama A, Sugano S,et al. Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library [J]. Gene,1997,200
    (122):149-156.
    [63]Suzuki Y, Sugano S. Construction of a full-length enriched and a 5'-end-enriched cDNA library using the oligo-capping method[J]. Methods Mol Biol,2003,221(1): 73-91.
    [64]Edery I, Chu LL, Sonenberg N, et al. An efficient strategy to isolate full-length cDNAs based on an mRNA cap retention pro-cedure (CAPture) [J]. Mol Cell Biol, 1995,15(6):3363-3371.
    [65]Zhu YY, Machleder EM, Chenchik A, et al. Reverse transcriptase template switching: a SMART approach for full-length cDNA library construction[J]. Biotechniques, 2001,30(4):892-897.
    [66]Carninci P, Shibata Y, Hayatsu N, et al. Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes[J]. Genome Res,2000,10(10):1617-1630.
    [67]Seki M, Carninci P, NishiyamaY, et al. High-efficiency cloning Arabidopsis full-length cDNA by biotinylated CAP-trapper[J]. The plant Journal,1998,15(5):707-720.
    [68]Carninci P, Kvam C, Kitamura A, et al. High-efficiency full-length cDNA cloning by biotinylated CAP trapper[J]. Genomics,1996,37(3):327-336.
    [69]Carninci P, Westover A, Nishiyama Y, et al. High efficiency selection of full-length cDNA by improved biotinylated captrapper[J]. DNA Res,1997,4(1):61-66.
    [70]Efimov VA, Chakhmakhcheva OG, Archdeacon J, et al. Detection of the 5'-cap structure of messenger RNAs with the use of the cap-jumping approach[J]. Nucl Acids Res,2001,29(22):4751-4759.
    [71]Clepet C, Le Clainche I, Caboche M. Improved full-length cDNA production based on RNA tagging by T4 DNA ligase[J]. Nucleic Acids Res,2004,32(1):66.
    [72]http://www. clontech. com.
    [73]Siegei RS. Methlptroyphic yeast Pichia pastoris produced in high cell density fermentation with cell yields as vehide of recombinant Protein Production [J]. Biotechnology Bioengineering,1989,34:403-404.
    [74]Cregg JM, Tschopp JF, Stillman C, et al. High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast pichia.pastoris [J]. Bio/Technology,1987,5:479-485.
    [75]Sreekrishma K, Nelles L, Potenz R, et al. High-level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized and characterization in the methylotrophic yeast pichia pastoris [J]. Biochemistry[J].1989,28:4117-4125.
    [76]Lan CB. Protein expression in yeast as an approach to Production of recombinant malaria antigens [J]. Am J Trop Med Hyg,1994,50(4):120-126.
    [77]李晶,赵晓祥,沙长青,等.甲醇酵母基因表达系统的研究进展[J].生物工程进展,1999,19(2):17-20.
    [78]欧阳立明,张惠展,张嗣同.巴斯德毕赤酵母的基因表达系统研究进展[J].生物化学与生物物理进,2000,27(2):151-154.
    [79]彭毅,杨希才,康良仪.影响甲醇酵母外源蛋白表达的因素[J].生物技术通报,2000,4:33-36.
    [80]David R, Higgins, Cregg JM. Introduction to Pichia pastoris[J]. Methods in Molecular Biology,1998,103:1-15.
    [81]Cregg JM, Ceregino JL, Shi J,et al. Recombinant Protein expression in PichiaPastoris [J]. molecular Biotechnology,2000,16:23-52.
    [82]赵翔,霍克克,李育阳.毕赤酵母的密码子用法分析[J].生物工程学报,2000,6(3):308-312.
    [83]Scorer CA, Buckholz RG, Clare IJ, et al. The intracellular Production and secretion of HIV-1 envelope protein in the methylotrophic yeast Pichia Pas tor is[J]. Gene,1993, 136:111-119.
    [84]Baoxiu Qi, Frederic Beaudoin, Tom Fraser, et al. Identification of a cDNA encoding a novel C18-v9 polyunsaturated fatty acid-specific elongating activity from the docosahexaenoic acid (DHA)-producing microalga, Isochrysis galbana[J]. FEBS Letters,2002,510:59-165.
    [85]Smaboork J, Friseh EF, Maniatis T. Molecular Cloning:A Laboratory Manual [M] 2nded. New York:Cold Spring Harbor Laboratory Press,1989.
    [86]Invitrogen. A manual of methods for Expression of Recombinant Proteins in Pichia pastoris[M]. Carlsbad:Invitrogen Press,1999.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700